[HTML][HTML] Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

BJ Langford, M So, S Raybardhan, V Leung… - Clinical microbiology …, 2021 - Elsevier
Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

COVID-19 and solid organ transplantation: a review article

Y Azzi, R Bartash, J Scalea, P Loarte-Campos… - …, 2021 - journals.lww.com
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …

[HTML][HTML] Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

KJ Jager, A Kramer, NC Chesnaye, C Couchoud… - Kidney international, 2020 - Elsevier
The aim of this study was to investigate 28-day mortality after COVID-19 diagnosis in the
European kidney replacement therapy population. In addition, we determined the role of …

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

S Anand, M Montez-Rath, J Han, J Bozeman… - The Lancet, 2020 - thelancet.com
Background Many patients receiving dialysis in the USA share the socioeconomic
characteristics of underserved communities, and undergo routine monthly laboratory testing …

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

JH Ng, JS Hirsch, R Wanchoo, M Sachdeva… - Kidney international, 2020 - Elsevier
Given the high risk of infection-related mortality, patients with end-stage kidney disease
(ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of …

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

T Fiolet, A Guihur, ME Rebeaud, M Mulot… - Clinical microbiology …, 2021 - Elsevier
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …

COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider

CM Hsu, DE Weiner, G Aweh, DC Miskulin… - American Journal of …, 2021 - Elsevier
Rationale & Objective During the coronavirus disease 2019 (COVID-19) pandemic, patients
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …

COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment

K El Karoui, AS De Vriese - Kidney International, 2022 - Elsevier
The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19

S Shibata, H Arima, K Asayama, S Hoshide… - Hypertension …, 2020 - nature.com
Abstract Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected more than seven million people …

COVID-19 and the kidney: what we think we know so far and what we don't

SS Farouk, E Fiaccadori, P Cravedi, KN Campbell - Journal of nephrology, 2020 - Springer
The novel coronavirus disease infection (COVID-19) outbreak that was declared a global
pandemic in March 2020 had led to an internationally variable but concerning incidence of …